AstraZeneca and the Hungarian Nephrological Society enter into strategic cooperation
It is estimated that nearly 850 million people worldwide suffer from impaired kidney function and its complications, and all indications are that this will be one of the most threatening diseases in the future. In our country, about one and a half million people can be affected by chronic kidney disease, while depending on their progression, it can increase the risk of cardiovascular damage by up to 14 times.
Related news
Uk medicines authority registers AstraZeneca’s COVID-19 antibody Evusheld
AstraZeneca’s Evusheld has been approved for use by the Medicines…
Read more >U.S. Drug Administration approves long-acting antibody AstraZeneca Evusheld (AZD7442)
AstraZeneca’s Evusheld is a long-acting combination of antibodies (tixagevimab and…
Read more >Related news
Voluntary price restrictions on medicines come into effect today
.The government always acts against unjustified price increases in the…
Read more >The number of residential air conditioners in Hungary could increase by one million – so let’s choose wisely
The number of household air conditioners in Hungary has increased…
Read more >New Product Launches In Spain Hit New Low, Study Finds
Innovation in Spain’s FMCG sector is at a record low,…
Read more >